Clinical Trials Logo

Clinical Trial Summary

To show whether the artery first approach leads to equal or less rate of positive resection margins in pancreatic head cancer than the standard technique (ppWhipple only with standard Kocher's manoeuvre)


Clinical Trial Description

This is a prospective non-randomized trial with two study groups. The trial is designed to show if the ARTERY FIRST approach reduces the rate of R1 resections in patients undergoing surgery for cancer of the pancreatic head.

After the diagnosis of cancer of the pancreatic head by clinical, laboratory and imaging evaluation patients who are scheduled for resection will be screened for inclusion into the trial. Informed consent is obtained at least on the day before surgery and patients meeting the eligibility criteria will be enrolled into the study. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01332773
Study type Interventional
Source Heidelberg University
Contact Nuh N. Rahbari, MD
Phone +496221
Email nuh.rahbari@med.uni-heidelberg.de
Status Recruiting
Phase Phase 3
Start date March 2010
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT04823832 - Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer N/A